T2 Biosystms Inc (TTOO) Financials

$0.00

$-0.08 (-98.72%)

As on 04-Sep-2026 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$8 Mln

P/E Ratio

--

P/B Ratio

14.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	7.68	7.19	22.31	28.06	18.13	8.34
Cost of Revenue	13.57	15.36	21.14	20.70	21.28	16.76
Gross Profit	-5.89	-8.17	1.17	7.36	-3.15	-8.43
Operating Expenses	38.34	41.49	56.68	50.33	38.21	43.63
Operating Profit (EBIT)	-41.66	-49.66	-54.05	-42.97	-41.36	-52.06
Other Income	--	--	--	--	0.09	0.40
Profit before Tax	-42.95	-50.08	-62.00	-49.24	-46.80	-59.01
Provision for Tax	-0.13	0.69	1.05	4.25	2.41	4.11
Profit after Tax (Net Income)	-42.95	-50.08	-62.00	-49.24	-46.80	-59.01
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-62.65	-49.24	-46.80	-59.01

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-11.71	-28.04	-39.97	-12.90	8.73	-34.01
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.36	6.68	63.85	61.75	60.55	1.92
Current Liabilities	24.44	56.15	10.13	11.69	9.80	60.57
Total Liabilities	42.52	34.80	34.39	60.54	79.08	28.49

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	8.30	9.61	14.97	16.15	25.49	9.59
Current Assets	9.79	25.19	19.42	44.39	53.58	18.90
Total Assets	42.52	34.80	34.39	60.54	79.08	28.49
Total Debt*	18.94	49.50	59.22	58.32	56.92	44.78
Net Current Assets	-14.65	-30.96	9.23	32.71	43.78	-41.68

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-48.14	-50.63	-38.87	-43.22	-45.36
Cash Flow from Investing Activities	--	-0.19	9.66	24.79	-36.26	-0.76
Cash from Financing Activities	--	52.69	29.05	20.54	85.61	6.35
Net Cash Inflow / Outflow	--	--	--	--	6.13	-39.77

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-6.41	-12.34	-8.03	-148.14	-158.10	-429.76
Cash EPS ($)	-0.03	-11.78	-7.74	-140.50	-147.44	-403.23
Adjusted Book Value ($)	-0.62	--	--	--	29.48	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-11.86	-6.56	-116.95	-146.00	-330.38
Free Cash Flow per Share ($)	--	-11.91	-6.60	-118.33	-148.71	-335.92

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-246.02	-191.76	-88.67	-122.48	-180.75
ROE (%)	--	147.27	234.54	2,357.72	370.25	521.76
ROA (%)	-60.82	-144.76	-130.63	-70.54	-87.01	-127.17
EBIT Margin (%)	-398.42	-621.91	-250.70	-155.62	-219.88	-623.17
Net Margin (%)	-559.52	-696.19	-277.98	-175.50	-256.92	-675.51
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-30.19	-0.68	-0.21	0.55	1.18	-0.21
EBIT Growth (%)	30.68	20.00	-28.06	-9.53	23.25	-16.97
Net Profit Growth (%)	13.81	19.23	-25.92	-5.22	20.69	-15.35
EPS Growth (%)	0.29	-0.54	0.95	0.06	0.63	-6.42
Book Value Growth (%)	84.77	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.51	-0.18	0.00	-0.01	0.00
Price / Book Value	14.50	-0.91	-0.27	-0.01	0.04	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.85	-1.35	-1.09	-0.64	-0.41	-0.70
Close Price ($)	1.97	6.28	142.00	2,581.00	6,200.00	5,850.00
High Price ($)	33.20	210.99	2,925.00	18,950.00	11,550.00	26,900.00
Low Price ($)	1.94	3.36	105.00	2,250.00	1,175.00	2,600.00
Market Cap ($ Cr)	0.03	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	-1.77	-1.48	-4.52	6.52	-1.32
Short term debt to equity ratio	-1.17	-1.53	-0.03	-0.09	0.13	-1.32
Current Ratio	0.40	0.45	1.92	3.80	5.47	0.31
Quick Ratio	0.24	0.36	1.49	3.46	5.10	0.25
Interest Coverage	-12.47	-8.37	-9.19	-5.75	-7.24	-7.07

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	26.48	19.74	9.70	18.30	28.12	33.89
Asset Turnover	0.11	0.21	0.47	0.40	0.34	0.18
Receivable days	--	90.97	59.75	66.60	79.82	101.03
Inventory Days	--	108.98	71.34	66.56	62.09	68.37
Payable days	--	33.56	35.66	43.14	49.87	48.99
Cash Conversion Cycle	--	166.39	95.43	90.03	92.04	120.41

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.